Back to AIM: Advocacy, Walks, and Fall Initiatives in Melanoma
…Steps Against Melanoma Long Island! If you live anywhere near Long Island, please consider volunteering, walking, sponsoring—or all three! Register…
Back to AIM: Advocacy, Walks, and Fall Initiatives in Melanoma
…Steps Against Melanoma Long Island! If you live anywhere near Long Island, please consider volunteering, walking, sponsoring—or all three! Register…
Uveal Melanoma Webinar: Part II — Navigating Treatment in the Metastatic Setting
…build a supportive community for those diagnosed with primary and/or metastatic ocular melanoma (OM). Part II of our uveal melanoma…
Lilly Pulitzer and AIM at Melanoma Partner for 5th Annual Community Giving Event
…fashion, sun safety, and melanoma awareness. On Friday, May 15, participating Lilly Pulitzer stores across the country will support AIM…
,
What I Want You To Know About Melanoma: Words of Wisdom From a Melanoma Survivor
Mindi Helmandollar-Armatas, (left) Stage IV Melanoma Survivor I was first diagnosed with Stage III melanoma when I was 22 years…
,
AIM at Melanoma + WEARSPF®: Partnering for a Cause This Melanoma Awareness Month
May is Melanoma Awareness Month—a time to come together, raise awareness, and take meaningful steps toward ending one of the…
,
A STORY OF LOVE AND HOPE: A Father, His Daughter, and a Box of Valentines
…confirmed it was melanoma. Stunned and shaking, he asked, “Is she on a timeline? Is it terminal?” Melanoma is notorious…
,
International Survivor Spotlight: Hedva Gonen, Israel
…to understand the gravity of the words “metastatic melanoma, Stage IV.” The fear came first, followed by a rush of…
,
,
President’s Letter | April 2024
…approval in February of Amtagvi (lifileucel), the TILs therapy for the treatment of metastatic melanoma (read about all FDA approved…
,
Inheriting Cancer Risk Factors
…back, one of the things she learned was that she had a mutation that puts her at high risk for…
Honoring Veterans and Raising Awareness About Skin Cancer
…post highlights veterans and sheds light on an important health issue affecting many who have served: skin cancer and melanoma.…
,
Recent Posts
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026
Promising early results with imneskibart, low-dose subcutaneous IL-2, and nivolumab in patients who do not respond to or who relapse after receiving combination checkpoint inhibitors
Jun. 05, 2026